baber/WOPTO huggingface dataset:
Patent FI-914023-A0 (FI)
Inventor: KEMP COLYN ROY
IPC: A61K8/41
Filed: 1991-08-26
Abstract: The invention relates to titanium dioxide sunscreen compositions containing 0.025 to 30 % by weight of phosphate anions. Phosphate anions, preferably in the form of salts, have been found to prevent or reduce the rate of discolouration of titanium dioxide-containing sunscreen compositions caused by light catalysed reduction of titanium (IV) to titanium (III). Discolouration caused by the presence of parahydroxybenzoic acid esters or para-aminobenzoic acids, esters or derivatives thereof in such compositions has also been found to be reduced by the incorporation of phosphate salt. Titanium dioxide particles having a mean primary particle size of less than 100 nm, each of the particles being substantially coated with phosphate anions are also described for use in sunscreen compositions.
Patent FI-916077-A0 (FI)
Inventor: URDAL DAVID L
IPC: C07K14/54
Filed: 1991-12-20
Abstract: The present invention provides a pharmaceutical compositions comprising as active ingredients certain truncated purified human IL-3(Pro8Asp15Asp70) analog proteins expressed by transformed yeast of the species Saccharomyces cerevisiae, which when administered to a primate do not result in detectable urticaria.
Patent FI-921490-A0 (FI)
Inventor: LEWIS RICHARD
IPC: E01C5/00
Filed: 1992-04-03
Abstract: PCT No. PCT/GB90/01550 Sec. 371 Date May 14, 1992 Sec. 102(e) Date May 14, 1992 PCT Filed Oct. 9, 1990 PCT Pub. No. WO91/05914 PCT Pub. Date May 2, 1991.The invention relates to paving blocks or tiles or to wall tiles, and has for its objective to provide a block or tile shape giving substantial freedom to a designer in providing any one of a considerable number of available patterns employing numbers of blocks or tiles of the same size. This objective is met by a construction comprising a generally rectangular body (2) having two generally parallel sides (3) and two ends each formed by two curved surfaces (3, 5) one end being formed by two equally and oppositely curved convex surfaces (4) that meet on the general center plane of the block or tile, and the other end being formed by two equally and oppositely curved concave surfaces (4) that meet on the general center plane of the block or tile (1), all the curved surfaces being of the same curvature.
Patent FI-924921-A0 (FI)
Inventor: KLEILE ARMIN
IPC: G02C9/00
Filed: 1992-10-29
Abstract: The combination spectacles proposed comprise a frame and an attachment which can be mounted on the front of the frame, the front of the frame having, in the front surface at each end, a cavity designed to accommodate a projection on the attachment. Cavity and projection together form a snap-in joint, the cavities being slightly longer in the direction of the longitudinal axis of the frame front piece than the projections which engage in them.
Patent FI-931494-A0 (FI)
Inventor: CLARKSON KATHLEEN A
IPC: C11D7/42
Filed: 1993-04-01
Abstract: Disclosed are cellulase compositions containing one or more endoglucanase components and less than about 5 weight percent of CBH I type components. When incorporated into detergent compositions and used in acidic, neutral, or alkaline washing media, such cellulase compositions impart color retention/restoration properties as well as improved softening properties to cotton-containing fabrics. Additionally, such compositions impart reduced strength loss to cotton-containing fabrics as compared to cellulase compositions containing greater amount of CBH I type components. <IMAGE>
Patent FI-935472-A0 (FI)
Inventor: BARZASI ALAIN
IPC: C22C1/04
Filed: 1993-12-07
Abstract: The magnetic powder employed for the manufacture of sintered magnets of the RE-T-B class, where RE denotes at least one rare earth, T at least one transition element and B boron, consists of the mixture of 2 powders (A) and (B):   a) the powder (A) consisting of grains of RE2T14B tetrahedral structure, T being essentially iron with Co/Fe < 8 % being also capable of containing up to 0.5 % Al, up to 0.05 % Cu and up to 4 % in all of at least one element from the group consisting of V, Nb, Hf, Mo, Cr, Ti, Zr, Ta, W and of the unavoidable impurities, with a Fisher particle size of between 3.5 and 5  mu m; b) the powder (B) being rich in RE and containing Co, having the following composition by weight: RE 52-70 %, including at least 40 % (in absolute value) of one (or more) light rare earth(s) chosen from the group consisting of La, Ce, Pr, Nd, Sm and Eu; Co 20-35 %; Fe 0-20 %; B 0-0.2 %; Al 0.1-4 %; and unavoidable impurities, with a Fisher particle size of between 2.5 and 3.5  mu m.   The powder (B) may be obtained by mixing a RE-rich powder (C) containing Co with a B-rich powder (D). <IMAGE>
Patent FI-945476-A0 (FI)
Inventor: MILLER RONALD BROWN
IPC: A61K31/137
Filed: 1994-11-22
Abstract: A process for the manufacture of particles comprises mechanically working a mixture of a drug and a hydrophobic and/or hydrophilic fusible carrier in a high speed mixture so as to form agglomerates, breaking the agglomerates to give controlled release particles and optionally continuing the mechanical working with the optional addition of a low percentage of the carrier or diluent.
Patent FI-955721-A0 (FI)
Inventor: ROSENBERG STEVEN
IPC: A61P7/04
Filed: 1995-11-27
Abstract: Unfucosylated huPAR polypeptides that contains huPA1-48 (SEQ ID NQ:22) are provided. These polypeptides are useful for treating diseases wherein antagonism of huPAR is therapeutically beneficial.
Patent FI-961238-A0 (FI)
Inventor: SCOTT RICHARD W
IPC: C12R1/645
Filed: 1996-03-15
Abstract: The invention generally features a novel recombinant DNA molecule useful for producing a heterologous protein, e.g., insulin-like growth factor-I, in yeast. The DNA molecule includes the following sequences joined in frame and in the following 5' to 3' progression: a sequence encoding a signal peptide of a yeast secreted protein; a sequence encoding at least 5 amino acids of the N-terminal region of a mature acid phosphatase protein, a sequence encoding a heterologous protein. Preferably the DNA molecule also encodes a spacer element that includes a proteolytic cleavage site.
Patent FI-971301-A0 (FI)
Inventor: IJAES VESA
IPC: D21F5/04
Filed: 1997-03-27
Abstract: The invention concerns a method in the dryer section of a paper or board machine for control of the curl of paper, in which method steam treatment and/or moistening of the paper web (W) is/are employed. In the method, the operations carried out in view of controlling the curl of the paper web (W) are carried out in a number of stages and/or when the web (W) temperature is lower than 85  DEG C, preferably lower than 75  DEG C, and/or when the dry solids content of the web (W) is in the range of K1...K2, wherein K1 = ultimate dry solids content - 7 % and K2 = ultimate dry solids content + 3 %. Further, the invention concerns a paper or board machine, which comprises at least a headbox, a former, a press, and a dryer section, in which steam boxes or moistening devices are employed for control of the curl. There are at least two of said curl regulation devices in view of achieving a regulation of the curl in a number of stages, and/or said curl regulation devices have been fitted to operate in an area in which the web temperature is lower than 85  DEG C, preferably lower than 75  DEG C, and/or the dry solids content of the web is in a range of K1...K2, wherein K1 = ultimate dry solids content - 7 % and K2 = ultimate dry solids content + 3 %.
Patent FI-980395-A0 (FI)
Inventor: FANDREY PETER
IPC: F04D1/06
Filed: 1998-02-20
Abstract: PCT No. PCT/EP96/03806 Sec. 371 Date Feb. 26, 1998 Sec. 102(e) Date Feb. 26, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/08461 PCT Pub. Date Mar. 6, 1997Side-channel centrifugal pump in sectional construction, the stage packs of which comprise a suction connector (6), a pressure connector (7), a vane (10) and a casing shell element (8, 9). In order to reduce the structural complexity, the suction and pressure connectors (6, 7) are formed as sheet-metal parts and are disposed in an annular casing shell element (8, 9). The centering of the suction and pressure connectors (6, 7) is expediently effected from the shaft.
Patent IL-75535-A0 (IL)
Title: High power window and support structure for electron beam processors
IPC: H01J33/04
Filed: 1985-06-17
Abstract: A high power window for an evacuated electron beam generator and the like which comprises one or more pluralities of conductive successive fins parallely and closely spaced arcuately extending transversely across the electron beam foil window and held by the vacuum pressure to the inner surface thereof, with the fin cross-section preferably tapering in thickness inwardly.
Patent IL-91292-A0 (IL)
Title: 13,17-propionic acid and propionic acid derivative substituted porphyrin complex compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: A61K31/40
Filed: 1989-08-11
Abstract: Porphyrin complex compounds consisting of at least one porphyrin ligand, optionally at least one ion of an element of atomic numbers 5, 13, 21-32, 37-39, 42-44, 49, 50 or 57-83 as well as optionally cations of inorganic and/or organic bases, amino acids or amino acid amides, are valuable diagnostic media and therapeutic agents.
Patent IL-95925-A0 (IL)
Title: Process for the preparation of alkoxybenzaldehydes
IPC: C07C47/58
Filed: 1990-10-09
Abstract: Process for the preparation of alkoxybenzaldehydes from halobenzaldehydes. The invention relates more particularly to the preparation of 3-alkoxy-4-hydroxybenzaldehydes from 3-halo-4-hydroxy- benzaldehydes and of 5-alkoxy-2-hydroxybenzaldehydes from 5-halo- 2-hydroxybenzaldehydes. More precisely, the invention consists of a process for the preparation of alkoxybenzaldehydes by reaction of halobenzaldehydes with an alkali metal or alkaline-earth metal alcoholate in the presence of copper or of a copper compound, characterised in that it is carried out in the presence of an effective quantity of an organic carbonate, of a mixed organometallic carbonate, of carbon dioxide or of a compound capable of forming carbon dioxide in the reaction mixture.
Patent SE-8901581-A0 (SE)
Title: Sätt att reglera en tryckluftunderstödd fordonsfjädring
Inventor: FAHRNSCHON M
IPC: B62D61/12
Filed: 1989-05-02
Abstract: 16 s Vid separat tryck- och nivareglering pa hoger och vanster fordonssida hos luftfjadrade fordon kan det forekomma att efter avslutad reglering trycket i det vanstra luftfjaderelementet (1) avsevart avviker fran trycket I det hOgra (2). Detta kan I hOg grad negativt paverka kOregenskaperna och vaggreppet. Med anvandande av fOr nivaregleringen nOdvandiga ventiler (25, 26, 27), rbrelsesensorer (5, 6) och trycksensorer (9, 10) abrjes medelst en stryanordning (15) fOr att tryckskillnaden sankes mellan luftfjaderelementen (1 och 2). Detta sker med minimal luftforbrukning, pa kort tid och utan att luftfjaderelementens (1, 2) niva lamnar forutbestamda granser. Sattet kan tillampas vid samtliga luftfjadrade fordon, exempelvis hussar och lastbilar, och ar speciellt gynnsamt vid lastbilar med an lyftaxel.
Patent AU-PO190596-A0 (AU)
Title: Oligosaccharide synthesis
IPC: C07C257/06
Filed: 1996-08-26
Abstract: The invention provides a system for solid-phase synthesis of oligosaccharides, based on the discovery that a 2-substituted-1,3-dioxocycloalkyl linker group of general formula (I) can be used to couple saccharide groups of both the O-glycoside and N-glycoside type to a polymer support. The invention provides reagents, reagent kits and methods for solid-phase oligosaccharide synthesis.
Patent AU-PP313798-A0 (AU)
Title: Improved evoked response audiometer
IPC: A61B5/12
Filed: 1998-04-22
Abstract: An evoked response audiometer method and apparatus in which a patient receives an auditory stimulus signal comprising a carrier frequency which is periodically amplitude modulated and frequency modulated whereby the stimulus is at least substantially frequency specific, the brain potential signals of the patient evoked by the auditory signal being sampled to determine whether phase locking to the modulated auditory signal has occurred, the auditory signal being selectively controlled to advance or delay one modulation with respect to the other modulation to cause enhancement of the evoked response to the auditory stimulus.
Patent AU-PP933499-A0 (AU)
Title: Process for the removal of oxalate and/or sulphate from bayer liquors
IPC: C01F7/473
Filed: 1999-03-19
Abstract: A process for the removal and causticisation of sodium oxalate and/or sodium sulphate from a Bayer process liquor containing sodium carbonate and one or both of sodium oxalate and sodium sulphate in an alumina refinery is described. The process is based on the observation that to efficiently causticise sodium oxalate solutions, it is first necessary to remove the aluminate ion from solution, optionally with recovery of the aluminate ion in some later step. This is effected by removing aluminate ions from the Bayer liquor through the formation of a carbonate bearing hydrocalumite and/or sulpha-bearing hydrocalumite. The liquor may then be treated with sufficient lime to remove and causticise any residual carbonate ions and some or all of the oxalate ions present so that any reacted lime solids thus formed can be separated and safely disposed of. The process may include a pre-causticisation step in which the Bayer liquor is first causticised to reduce the concentration of carbonate ions, prior to the step of removing aluminate ions. The invention provides an effective process for the removal of sodium sulphate and a practical method for the recovery of soda from sodium sulphate. The efficiency of lime utilisation can also be dramatically increased from about 20% to 80% (if sulphate removal is not the objective) wherein alumina losses can be minimised. The oxalate concentration of the process liquor is also substantially lower than can usually be achieved in processes based on sodium oxalate-crystallisation.
Patent FI-20001700-A0 (FI)
Inventor: GEFWERT BORIS
IPC: H04L29/06
Filed: 2000-07-21
Abstract: The invention relates to a method and arrangement for managing data transmission in a data network. In particular, the invention relates to the transmission of confidential information in a data network. One of the basic principles of the invention is that when the information meant for the user is recorded (413), the address of the storage location is transmitted to the user by intermediation of a reliable party (intermediator, 440). Thus, on the basis of a user verification carried out by the intermediator, the user can access the information/services of several different service producers. <IMAGE>
Patent FI-20022142-A0 (FI)
Inventor: KAIJAERVI MIKKO
IPC: H01L23/467
Filed: 2002-12-04
Abstract: The invention relates to a cooling arrangement for an electric appliance unit. The electric appliance unit (1) comprises a housing (2), inside which there area arranged electric and/or electronic components, such as relays, semiconductors and resistors, as well as their wiring and support structures. The electric appliance unit (1) can be attached by suitable fastening elements (3) to an electric control center together with other corresponding units. According to the invention, the cooling arrangement comprises a vertical cooling channel (5) fitted through the housing (2), through which cooling channel the cooling air is arranged to flow (a, b); in connection with said cooling channel (5), there is installed at least one device, device element or component with a high cooling demand, such as a high-power semiconductor (P).
Patent FI-20106264-A0 (FI)
Inventor: KATTAINEN ARI
IPC: B66B/
Filed: 2010-12-01
Abstract: The invention relates to a safety circuit of an elevator and also to a method for identifying a functional nonconformance of the safety circuit of an elevator. In the method a message is formed in node A, a testing field is added to the message for testing the operation of the safety circuit of an elevator, and the aforementioned message containing the testing field is sent from node A to the communications bus in the safety circuit of the elevator.
Patent IL-102183-A0 (IL)
Title: Heterocyclic compounds,their production and use
IPC: A61K31/495
Filed: 1992-06-12
Abstract: Compounds shown by the above formula or salt thereof show a strong angiotensin II antagonistic activity and hypotensive action and CNS activity, and are useful as therapeutic agents of circulatory diseases such as hypertensive diseases and heart diseases (e.g. hypercardia, heart failure, cardiac infarction), strokes, cerebral apoplexy, nephritis, atherosclerosis, Alzheimer's disease, senile dementia, etc. <CHEM> h
Patent IL-105413-A0 (IL)
Title: Aqueous gel retinoid compositions
IPC: A61K31/19
Filed: 1993-04-15
Abstract: This invention relates to aqueous gel retinoid compositions and their methods of use. More specifically, the aqueous gel retinoid compositions of the invention utilize micronized particles of retinoids, particularly tretinoin, to provide an aqueous gel for topical application of such retinoids to the skin which minimizes skin irritation while retaining drug efficacy.
Patent IL-105558-A0 (IL)
Title: Therapeutic alcohols
IPC: C07C49/835
Filed: 1993-04-30
Abstract: Compounds of formula I    <IMAGE>  I  wherein X, A, B, R1 and R2 have the meanings given in the specification, and pharmaceutically acceptable salts and pharmaceutically acceptable in vivo hydrolysable ester thereof, processes for preparing the compounds and pharmaceutical compositions comprising them. The compounds are useful as potassium channel openers and as therapeutic agents in the treatment of urinary incontinence.
Patent IL-108767-A0 (IL)
Title: Process for the preparation of 6-alkyl-4-(pyridin-3-yl-methyleneamino)-4,5-dihydro-1,2,4-triazin-3 (2h)-one
IPC: A01N43/707
Filed: 1994-02-24
Abstract: A process for the preparation of 6-alkyl-4-(pyridin-3-yl-methyleneamino)-4,5-dihydro-1,2,4-triazin-3(2H )-one by the reaction of 4-amino-6-alkyl-3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine with 3-cyanopyridine wherein the reaction is carried out under catalytic hydrogenation conditions in the presence of a Raney-nickel catalyst in an aqueous alcoholic medium, at a temperature between 0 and 70 DEG C, at a pH of between 2 and 7, and in the presence of and a C1-C6-carboxylic acid or a C1-C6-carboxylic acid alkali metal salt or both, whereby the hydrogen pressure is between 0.1 and 10 bar.
Patent IL-112106-A0 (IL)
Title: Accelerated release composition containing bromocriptine
IPC: A61K47/12
Filed: 1994-12-21
Abstract: Disclosed herein is a solid oral dosage form comprising bromocriptine and one or more pharmaceutically acceptable excipients. The oral dosage form has a dissolution rate in excess of 90% in 5 minutes in 500 ml of 0.1N HCl aqueous medium at 37 DEG C and is useful for adjusting the plasma prolactin profile of a patient.
Patent IL-113101-A0 (IL)
Title: Anthracycline derivatives and their preparation
IPC: A61K31/704
Filed: 1995-03-23
Abstract: Conjugates of general formula 1:[A-O-W-Z]a-T1wherein the moiety A-O- is the residue of drug of formula A-O-H in which -O-H is a primary or secondary hydroxyl group; a is an integer of from 1 to 30; W is a group of general formula 2:    <IMAGE>  2  wherein b is an integer of from 1 to 4, B represents a C1-C3 alkylene group and R1 and R2 each independently represent hydrogen, halogen, alkyl, phenyl or substituted phenyl; Z is a spacer group and T is a carrier moiety.
Patent IL-117971-A0 (IL)
Title: Method for treating dyskinesias
IPC: C07D409/04
Filed: 1996-04-18
Abstract: Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thienoÄ2,3-bÜ Ä1,5Ü benzodiazepine, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for treating a dyskinesia.
Patent IL-124951-A0 (IL)
Title: Taxane derivatives having a pyridyl substituted c13 chain a process for their preparation and pharmaceutical compositions containing the same
IPC: A61K31/44
Filed: 1997-01-31
Abstract: PCT No. PCT/EP97/00440 Sec. 371 Date Jul. 30, 1998 Sec. 102(e) Date Jul. 30, 1998 PCT Filed Jan. 31, 1997 PCT Pub. No. WO97/28156 PCT Pub. Date Aug. 7, 1997The invention relates to pharmacologically active compounds that have the ability to influence the polymerisation and depolymerisation of tubulin. A range of natural mitosis toxins are used as anti-tumor agents or are in the process of being clinically tested. There are various classes of such mitosis toxins that either demonstrate their cytotoxic action by inhibiting the polymerisation of microtubules in the spindle system (for example, Vinca alkaloids, colchicine) or achieve their cytotoxic action by a GTP-independent increase in the polymerisation of the tubulin and by preventing the depolymerisation of microtubules (for example, taxol, taxoters). Owing to their physico-chemical properties, hitherto not understood, and as a result of the characteristics of neoplastic cells, mitosis toxins have a certain selectivity for tumor cells, but there still remains a not inconsiderable cytotoxicity towards non-transformed cells. The search for more selective compounds that are easier to manufacture and-like the taxane class of substances-are able to inhibit the depolymerisation of microtubules, had, surprisingly, led to the discovery of borneol esters, as described in P 4416374.6 and 19513040.5. Structural modifications in that class of compounds have revealed a considerable potential for optimisation in respect of the action on microtubules. Outstanding results have been obtained, inter alia, by formal esterification of those broneols with an acid of the Sk-H type. By synthesising the taxol derivatives described herein, in which the isoserine chain of the taxol has been replaced by Sk, the intention was to study whether it is also possible in that class of substances to achieve an improved stabilisation of microtubules, compared with taxol.
Patent IL-126338-A0 (IL)
Title: Method and apparatus for performing preferred system selection
IPC: H04W8/18
Filed: 1997-03-26
Abstract: A method and apparatus for selecting a communication system in accordance with the geographic region in which the subscriber station is located is described. Upon successful acquisition, a system determination processor examines the received system identification information and compares it with system identification information stored in a universal system table to determine the geographical region of the identified communication system. The system determination processor then determines whether the acquired system is the most desirable system for use in the geographical region. If it is the most desirable system for use in the geographical region, the system determination processor selects the acquired system for providing service. If it is not the most desirable system for use in the geographical region, the subscriber station attempts to acquire a more desirable system using information from the universal system table.
Patent IL-128690-A0 (IL)
Title: Cyclic amine derivatives pharmaceutical compositions containing the same and use thereof
IPC: A61K31/40
Filed: 1997-08-28
Abstract: Cyclic amine compounds of formula R1-R2CH-R3 (I) are new. R1 = phenyl optionally substituted by 1-4C alkyl, halo, fluoro-substituted 1-4C alkyl, 1-4C alkoxy, fluoro-substituted 1-4C alkoxy, cyano or nitro; R2 = 1-8C aliphatic acyl optionally substituted by halo, OH, 1-4C alkoxy or cyano; benzoyl optionally substituted by 1-4C alkyl, halo or 1-4C alkoxy; or (1-4C alkoxy)carbonyl; R3 = optionally condensed 3-7 membered cyclic saturated amino group substituted by optionally protected mercapto or 1-4C alkyl optionally substituted by optionally protected mercapto; CR4R5 (mercapto-protecting groups are 1-20C alkanoyl, 3-20C alkenoyl, benzoyl optionally substituted by 1-4C alkyl, halogen or 1-4C alkoxy); or (1-4C alkoxy)carbonyl; and R4, R5 = H, 1-4C alkyl, carboxy, (1-4C alkoxy) carbonyl, carbamoyl or mono- or di-(1-4C alkyl)carbamoyl.